Insilico Medicine, an AI-driven drug discovery company headquartered in the U.S. and Hong Kong, announced on the 24th (local ...

What if you could protect yourself from several different types of cancer with foods you already love? We often hear that ...

New Preclinical Results at AACR 2026 Show Plinabulin Dramatically Improves Complete Response Rates and Survival When Combined with Leading ADC ...

A new set of drugs exploit a recently revealed weakness in "zombie-like"—or senescent—cells that could lead to new treatments ...

A KAIST research team has identified the real reason why anticancer drugs kill cancer cells—targeted anticancer therapies do ...

A research team co-led by chemists from City University of Hong Kong (CityU) recently discovered novel, highly effective anticancer agents with tridimensional structures, which have high anticancer ...

An emerging class of anticancer drugs called EZH2 inhibitors may greatly enhance the potency of some cancer immunotherapies. An emerging class of anticancer drugs called EZH2 inhibitors may greatly ...

A groundbreaking anticancer treatment technology that selectively targets cancer cell lysosomes and overcomes drug resistance has been developed by Professor Ja-Hyoung Ryu and his research team in the ...

Earlier this month to mark World Cancer Day, Imperial College Healthcare NHS Trust confirmed that the first UK patients had received an experimental mRNA anticancer vaccine, mRNA-4359, as part of a ...